Lv62
2610 积分 2021-02-22 加入
Practical considerations for navigating the regulatory landscape of non-clinical studies for clinical translation of radiopharmaceuticals
1个月前
已完结
US and EU radiopharmaceutical diagnostic and therapeutic nonclinical study requirements for clinical trials authorizations and marketing authorizations
1个月前
已完结
Radiopharmaceutical: An Update and Comparison of Preclinical Investigation Result of Alpha and Beta Emitter Radioisotope
1个月前
已完结
Production of No-Carrier Added Lutetium-177 by Irradiation of Enriched Ytterbium-176
1个月前
已完结
Production of 177Lu for Targeted Radionuclide Therapy: Available Options
1个月前
已完结
Beyond NAMs versus animal models: Context of use as the governing framework for integrated nonclinical strategies in drug development
1个月前
已完结
Lead radionuclides for theranostic applications in nuclear medicine: from atom to bedside
1个月前
已完结
A CDER perspective: Landscape of New Approach Methodologies (NAMs) submitted in drug development programs
2个月前
已完结
皖公网安备34019202002308
